Satya Nadella has unveiled BioEmu, Microsoft's new AI initiative aimed at accelerating drug discovery processes.

OpenAI’s contract clause could cut off Microsoft’s access to new AI models if AGI is declared, forcing high-stakes renegotiation of their partnership.

Microsoft's new AI system BioEmu will help decode protein motion and help in faster discovery of drugs, said CEO Satya ...

The most important AI partnership in the world partly revolves around whether OpenAI achieves AGI. I propose several ...

Microsoft's CEO, Satya Nadella, has announced BioEmu-1, a new AI system designed to accelerate drug discovery by decoding ...

Microsoft is laying off around 9,000 more employees after earmarking thousands of H-1B positions in the months leading up to ...

The Power of Buy-and-Hold Investing Buy-and-hold investing is a time-tested strategy that rewards patience and a long-term ...

Microsoft is laying off thousands of employees, even as its profits and stock price hit historic highs. For many worried ...

Nvidia and Microsoft are making history as they reach a $4 trillion market cap, highlighting AI's transformative power and ...

Microsoft says it is laying off about 9,000 workers, its second mass layoff in months and its largest in more than two years.

Microsoft India partners with governments, as well as private and public institutions to develop cloud-based technological ...

Satya Nadella stresses AI must deliver real-world value amid rising job cuts, energy usage, and Microsoft's major AI-led ...